1066 related articles for article (PubMed ID: 27198892)
1. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
[TBL] [Abstract][Full Text] [Related]
2. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted imaging in hypertrophic cardiomyopathy: association with high T2-weighted signal intensity in addition to late gadolinium enhancement.
Shi RY; An DA; Chen BH; Wu R; Du L; Jiang M; Xu JR; Wu LM
Int J Cardiovasc Imaging; 2020 Nov; 36(11):2229-2238. PubMed ID: 32666169
[TBL] [Abstract][Full Text] [Related]
4. T1 mapping in children and young adults with hypertrophic cardiomyopathy.
Parekh K; Markl M; Deng J; de Freitas RA; Rigsby CK
Int J Cardiovasc Imaging; 2017 Jan; 33(1):109-117. PubMed ID: 27659477
[TBL] [Abstract][Full Text] [Related]
5. The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus.
Wu R; An DA; Hu J; Jiang M; Guo Q; Xu JR; Wu LM
Acta Radiol; 2018 Mar; 59(3):287-295. PubMed ID: 28679323
[TBL] [Abstract][Full Text] [Related]
6. Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy--comparison with late enhancement quantification.
Małek ŁA; Werys K; Kłopotowski M; Śpiewak M; Miłosz-Wieczorek B; Mazurkiewicz Ł; Petryka-Mazurkiewicz J; Marczak M; Witkowski A
Magn Reson Imaging; 2015 Jul; 33(6):718-24. PubMed ID: 25863138
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
8. Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
Thompson EW; Kamesh Iyer S; Solomon MP; Li Z; Zhang Q; Piechnik S; Werys K; Swago S; Moon BF; Rodgers ZB; Hall A; Kumar R; Reza N; Kim J; Jamil A; Desjardins B; Litt H; Owens A; Witschey WRT; Han Y
J Cardiovasc Magn Reson; 2021 Oct; 23(1):120. PubMed ID: 34689798
[TBL] [Abstract][Full Text] [Related]
9. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
[TBL] [Abstract][Full Text] [Related]
10. Endogenous assessment of late gadolinium enhancement grey zone in patients with non-ischaemic cardiomyopathy with T1ρ and native T1 mapping.
Dong Z; Yin G; Yang K; Jiang K; Wu Z; Chen X; Song Y; Yu S; Wang J; Yang S; Ma X; Xu Y; Zhao K; Lu M; Xu X; Zhao S
Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):492-502. PubMed ID: 35793269
[TBL] [Abstract][Full Text] [Related]
11. Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance.
Nguyen C; Lu M; Fan Z; Bi X; Kellman P; Zhao S; Li D
J Cardiovasc Magn Reson; 2015 Dec; 17():107. PubMed ID: 26631061
[TBL] [Abstract][Full Text] [Related]
12. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
13. Histogram Analysis of Native T
Wu CW; Wu R; Shi RY; An DA; Chen BH; Jiang M; Bacyinski A; Rahim A; Deen JM; Hu J; Han TT; Xu JR; Wu LM
J Magn Reson Imaging; 2019 Mar; 49(3):668-677. PubMed ID: 30142234
[TBL] [Abstract][Full Text] [Related]
14. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
[TBL] [Abstract][Full Text] [Related]
15. The feasibility and diagnostic value of intravoxel incoherent motion diffusion-weighted imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy patients.
Wu R; An DA; Shi RY; Chen BH; Wu CW; Jiang M; Xu JR; Wu LM; Pu J
Eur J Radiol; 2020 Nov; 132():109333. PubMed ID: 33068839
[TBL] [Abstract][Full Text] [Related]
16. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
[TBL] [Abstract][Full Text] [Related]
17. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.
Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J
Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228
[TBL] [Abstract][Full Text] [Related]
18. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
19. MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.
Xu J; Zhuang B; Sirajuddin A; Li S; Huang J; Yin G; Song L; Jiang Y; Zhao S; Lu M
Radiology; 2020 Feb; 294(2):275-286. PubMed ID: 31769741
[TBL] [Abstract][Full Text] [Related]
20. Performance of native and contrast-enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques.
Nadjiri J; Nieberler H; Hendrich E; Greiser A; Will A; Martinoff S; Hadamitzky M
Int J Cardiovasc Imaging; 2017 Apr; 33(4):539-547. PubMed ID: 27878700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]